372 related articles for article (PubMed ID: 17143529)
1. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
Festuccia C; Gravina GL; Muzi P; Pomante R; Ventura L; Ricevuto E; Vicentini C; Bologna M
Prostate; 2007 Sep; 67(12):1255-64. PubMed ID: 17596848
[TBL] [Abstract][Full Text] [Related]
3. Mixed-lineage kinase inhibitors require the activation of Trk receptors to maintain long-term neuronal trophism and survival.
Wang LH; Paden AJ; Johnson EM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1007-19. PubMed ID: 15525794
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors.
Skoff AM; Adler JE
Exp Neurol; 2006 Feb; 197(2):430-6. PubMed ID: 16300761
[TBL] [Abstract][Full Text] [Related]
5. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
Chen-Tsai CP; Colome-Grimmer M; Wagner RF
Dermatol Surg; 2004 Jul; 30(7):1009-16. PubMed ID: 15209791
[TBL] [Abstract][Full Text] [Related]
6. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
Weeraratna AT; Dalrymple SL; Lamb JC; Denmeade SR; Miknyoczki S; Dionne CA; Isaacs JT
Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797
[TBL] [Abstract][Full Text] [Related]
7. Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis.
Raap U; Fokkens W; Bruder M; Hoogsteden H; Kapp A; Braunstahl GJ
Allergy; 2008 Apr; 63(4):468-75. PubMed ID: 18266897
[TBL] [Abstract][Full Text] [Related]
8. Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts.
Pinski J; Weeraratna A; Uzgare AR; Arnold JT; Denmeade SR; Isaacs JT
Cancer Res; 2002 Feb; 62(4):986-9. PubMed ID: 11861369
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
Dionne CA; Camoratto AM; Jani JP; Emerson E; Neff N; Vaught JL; Murakata C; Djakiew D; Lamb J; Bova S; George D; Isaacs JT
Clin Cancer Res; 1998 Aug; 4(8):1887-98. PubMed ID: 9717816
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
Sigala S; Bodei S; Missale C; Zani D; Simeone C; Cunico SC; Spano PF
Mol Cell Endocrinol; 2008 Mar; 284(1-2):11-20. PubMed ID: 18280641
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor signaling in prostate health and disease.
Arrighi N; Bodei S; Zani D; Simeone C; Cunico SC; Missale C; Spano P; Sigala S
Growth Factors; 2010 Jun; 28(3):191-201. PubMed ID: 20166899
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
[TBL] [Abstract][Full Text] [Related]
15. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
Chen J; Zhe X
Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
[TBL] [Abstract][Full Text] [Related]
16. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
Delsite R; Djakiew D
J Androl; 1996; 17(5):481-90. PubMed ID: 8957691
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of neurotrophic factors and their receptors in prostate cancer].
Liu M; Su YH; Chen Y
Zhonghua Nan Ke Xue; 2010 Feb; 16(2):129-31. PubMed ID: 20369695
[TBL] [Abstract][Full Text] [Related]
19. Regulation of NGF responsiveness in human neuroblastoma.
Bogenmann E; Peterson S; Maekawa K; Matsushima H
Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
[TBL] [Abstract][Full Text] [Related]
20. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
